Proton MR Spectroscopy Improves Discrimination between Tumor and Pseudotumoral Lesion in Solid Brain Masses

References

1. ↵
   Paley RJ, Persing JA, Doctor A, et al. Multiple sclerosis and brain tumor: a diagnostic challenge. J Emerg Med 1989;7:241–44

   CrossRefPubMed
2. Giang DW, Poduri KR, Eskin TA, et al. Multiple sclerosis masquerading as a mass lesion. Neuroradiology 1992;34:150–54

   CrossRefPubMedWeb of Science
3. Hunter SB, Ballinger WE Jr, Rubin JJ. Multiple sclerosis mimicking primary brain tumor. Arch Pathol Lab Med 1987;111:464–68

   PubMedWeb of Science
4. Kurihara N, Takahashi S, Furuta A, et al. MR imaging of multiple sclerosis simulating brain tumor. Clin Imaging 1996;20:171–77

   CrossRefPubMedWeb of Science
5. Mastrostefano R, Occhipinti E, Bigotti G, et al. Multiple sclerosis plaque simulating cerebral tumor: case report and review of the literature. Neurosurgery 1987;21:244–46

   PubMedWeb of Science
6. ↵
   Silva HC, Callegaro D, Marchiori PE, et al. Magnetic resonance imaging in five patients with a tumefactive demyelinating lesion in the central nervous system. Arq Neuropsiquiatr 1999;57:921–26

   CrossRefPubMed
7. ↵
   Tate AR, Underwood J, Acosta D, et al. Development of a decision support system for diagnosis and grading of brain tumours using in vivo magnetic resonance single voxel spectra. NMR Biomed 2006;19:411–34

   CrossRefPubMedWeb of Science
8. Preul MC, Caramanos Z, Collins DL, et al. Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy. Nat Med 1996;2:323–25

   CrossRefPubMedWeb of Science
9. Majós C, Alonso J, Aguilera C, et al. Proton magnetic resonance spectroscopy (1H MRS) of human brain tumours: assessment of differences between tumour types and its applicability in brain tumour categorization. Eur Radiol 2003;13:582–91

   PubMed
10. Dowling C, Bollen AW, Noworolski SM, et al. Preoperative proton MR spectroscopy imaging of brain tumors: correlation with histopathologic analysis of resection specimens. AJNR Am J Neuroradiol 2001;22:604–12

    Abstract/FREE Full Text
11. Burtscher IM, Skagerberg G, Geijer B, et al. Proton MR spectroscopy and preoperative diagnostic accuracy: an evaluation of intracranial mass lesions characterized by stereotactic biopsy findings. AJNR Am J Neuroradiol 2000;21:84–93

    Abstract/FREE Full Text
12. ↵
    Howe FA, Barton SJ, Cudlip SA, et al. Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy. Magn Reson Med 2003;49:223–32

    CrossRefPubMed
13. ↵
    Rand SD, Prost R, Haughton V, et al. Accuracy of single-voxel proton MR spectroscopy in distinguishing neoplastic from nonneoplastic brain lesions. AJNR Am J Neuroradiol 1997;18:1695–704

    Abstract
14. ↵
    Butzen J, Prost R, Chetty V, et al. Discrimination between neoplastic and nonneoplastic brain lesions by use of proton MR spectroscopy: the limits of accuracy with a logistic regression model. AJNR Am J Neuroradiol 2000;21:1213–19

    Abstract/FREE Full Text
15. ↵
    De Stefano N, Caramanos Z, Preul MC, et al. In vivo differentiation of astrocytic brain tumors and isolated demyelinating lesions of the type seen in multiple sclerosis using 1H magnetic resonance spectroscopic imaging. Ann Neurol 1998;44:273–78

    CrossRefPubMedWeb of Science
16. ↵
    Hourani R, Brant LJ, Rizk T, et al. Can proton MR spectroscopic and perfusion imaging differentiate between neoplastic and nonneoplastic brain lesions in adults? AJNR Am J Neuroradiol 2008;29:366–72

    Abstract/FREE Full Text
17. Saindane AM, Cha S, Law M, et al. Proton MR spectroscopy of tumefactive demyelinating lesions. AJNR Am J Neuroradiol 2002;23:1378–86

    Abstract/FREE Full Text
18. ↵
    Cianfoni A, Niku S, Imbesi SG. Metabolite findings in tumefactive demyelinating lesions utilizing short echo time proton magnetic resonance spectroscopy. AJNR Am J Neuroradiol 2007;28:272–77

    Abstract/FREE Full Text
19. ↵
    van den Boogaart A. Quantitative data analysis of in vivo MRS data sets. Magn Reson Chem 1997;35:S146–52

    CrossRefWeb of Science
20. ↵
    Tate AR, Griffiths JR, Martínez-Pérez I, et al. Towards a method for automated classification of 1H MRS spectra from brain tumours. NMR Biomed 1998;11:177–91

    CrossRefPubMedWeb of Science
21. ↵
    Ladroue C, Howe FA, Griffiths JR, et al. Independent component analysis for automated decomposition of in vivo magnetic resonance spectra. Magn Reson Med 2003;50:697–703

    CrossRefPubMed
22. ↵
    Hochberg Y, Tamhane AC, eds. Multiple Comparison Procedures. New York: Wiley;1987
23. ↵
    Obuchowski NA. Receiver operating characteristic curves and their use in radiology. Radiology 2003;229:3–8

    CrossRefPubMedWeb of Science
24. ↵
    Lin A, Bluml S, Mamelak AN. Efficacy of proton magnetic resonance spectroscopy in clinical decision making for patients with suspected malignant brain tumors. J Neurooncol 1999;45:69–81

    CrossRefPubMed
25. ↵
    Arnold DL, Matthews PM, Francis GS, et al. Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques. Ann Neurol 1992;31:435–41
26. Bitsch A, Bruhn H, Vougioukas V, et al. Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy. AJNR Am J Neuroradiol 1999;20:1619–27

    Abstract/FREE Full Text
27. Ernst T, Chang L, Walot I, et al. Physiologic MRI of a tumefactive multiple sclerosis lesion. Neurology 1998;51:1486–88

    Abstract/FREE Full Text
28. ↵
    Narayana PA. Magnetic resonance spectroscopy in the monitoring of multiple sclerosis. J Neuroimaging 2005;15:46S–57S.

    CrossRefPubMedWeb of Science
29. ↵
    Danielsen ER, Ross B. Magnetic Resonance Spectroscopy Diagnosis of Neurological Diseases. New York: Marcel Decker;1999 :30–34
30. ↵
    Castillo M, Smith JK, Kwock L. Correlation of myo-inositol levels and grading of cerebral astrocytomas. AJNR Am J Neuroradiol 2000;21:1645–49

    Abstract/FREE Full Text
31. ↵
    Londoño A, Castillo M, Armao D, et al. Unusual MR spectroscopic imaging pattern of an astrocytoma: lack of elevated choline and high myo-inositol and glycine levels. AJNR Am J Neuroradiol 2003;24:942–45

    Abstract/FREE Full Text